Deep vein thrombosis (DVT) is a widely encountered health condition in Western medical practice and is often comorbid with malignancy, post-surgical recovery, trauma, and immobilization. In most cases, it occurs spontaneously and manifests in acute leg issues, though sometimes, potentially fatal pulmonary embolism (PE) can occur. The article by Othieno et al. (2018) explores two primary anticoagulant treatments for deep vein thrombosis: unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). The authors compare the efficacy of these treatments in in-home and in-patient settings. The purpose is to fill the knowledge gap regarding the effectiveness and safety of LMWH in outpatient care, given the potential cost reduction and improved social acceptability this treatment entails.
The article rigorously evaluates the subject and applies high-quality research approaches, maintaining consistency and homogeneity of results from individual studies and other techniques to minimize potential bias. Othieno et al. (2018) rely on scholarly literature from reputable sources such as CINAHL and AMED, as well as on clinical trial results from the World Health Organization International Clinical Trials Registry Platform and other sources. The authors conclude that some evidence suggests that home treatment with LMWH is not more harmful than inpatient treatment with LMWH or UFH.
The paper does not aim to challenge any established views. Instead, it highlights the absence of such views on the matter due to insufficient research. Consequently, the authors urge greater efforts to investigate the subject, given its potential impact on industry standards and patient outcomes. In this sense, the article is mainly informative, though the authors admit that the results remain inconclusive due to the generally low quality of the available evidence (Othieno et al., 2018).
For this reason, the article warns stakeholders to address the remaining practical issues, including proper patient triage and admission, LMWH prescribing procedures, and professional training (Othieno et al., 2018). To address the lack of knowledge about the efficacy of home treatment for deep vein thrombosis, the authors highlighted the under-researched nature of the topic. Furthermore, the article highlights the poor quality of the available data. The paper does not intend to promote particular products or services, though the authors suggest that LMWH can be used more in clinical practice for in-home treatment.
In my opinion, this article emphasizes the issue with healthcare professionals’ culture of perceiving in-home treatment as inherently less reliable than inpatient therapy. One of the potential reasons is a bias of patients’ poor health knowledge and ability to conform to the prescribed therapy. This issue could explain the overall lack of studies in the discussed area and the seemingly lax attitudes toward data quality in the available studies. Overall, this information shows that such a culture of exclusivity and bias prevents clinical practice from advancing and achieving better treatment results while reducing associated costs.
The treatment of DVT is centered around preventing the clot from increasing in size and breaking loose due to the potential for causing the aforementioned pulmonary embolism. As Othieno et al. (2018) discuss, anticoagulant medications remain the most widely prescribed approach for the condition. Additionally, graduated compression stockings can be effective in preventing DVT in the legs, especially if combined with sufficient physical activity. A sedentary lifestyle and excessive weight are associated with DVT, so regular exercise is recommended to prevent and treat the issue. Intravenous thrombolytics can be prescribed in severe cases where the aforementioned approaches are ineffective.
Reference
Othieno, R., Okpo, E., & Forster, R. (2018). Home versus in‐patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews, 1-41.
